A major study suggests that semaglutide, also known by the brand name Ozempic, may reduce the risk of depression, anxiety, and addiction. The drug, which is used for weight loss, has been found to have potential benefits beyond weight loss, although the extent of these benefits is still being evaluated. Some reports indicate that GLP-1 drugs like Ozempic may be linked to a lower risk of anxiety and depression, but the distinction between scientific findings and hype is still being clarified.